Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-19
2006-09-19
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S235200, C514S309000, C514S310000, C514S312000, C514S313000, C544S105000, C544S128000, C546S141000, C546S143000, C546S153000, C546S157000, C546S159000, C546S171000
Reexamination Certificate
active
07109212
ABSTRACT:
The invention relates to quinoline and isoquinoline derivatives of general formula Iand a process for their production, and their use as inflammation inhibitors.
REFERENCES:
patent: 6323199 (2001-11-01), Lehmann et al.
patent: 2002/0077356 (2002-06-01), Jaroch et al.
patent: 2004/0116694 (2004-06-01), Jaroch et al.
patent: WO 0032584 (2000-06-01), None
Aoki et al., “Inhibitory Effect of a Novel Quinolinone Derivative, TA-270, on Asthmatic Inflammatory Responses in Sensitized Guinea Pigs,”European Journal of Pharmacology, 409 (2000) 325-330.
Search Report for Appl. No. PCT/EP03/03298 completed Jun. 2003.
Written Opinion for Appl. No. PCT/EP03/03298 completed Dec. 2003.
Berger Markus
Jaroch Stefan
Krolikiewicz Konrad
Lehmann Manfred
Rehwinkel Hartmut
Dentz Bernard
Millen White Zelano & Branigan P.C.
Schering AG
LandOfFree
Quinoline and isoquinoline derivatives, a process for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline and isoquinoline derivatives, a process for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline and isoquinoline derivatives, a process for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3556611